[1]
Silvestro, M. et al. 2025. Perceived ease-of-usability and local tolerability using CGRP monoclonal antibody autoinjectors <i>vs.</i> syringes: an online questionnaire-based study in patients with migraine. Confinia Cephalalgica. 34, 2 (Jan. 2025). DOI:https://doi.org/10.4081/cc.2024.15772.